Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Chuan Liu, Ling Yang, Hong You, Gao-Jun Teng, Xiaolong Qi

Clin Mol Hepatol. 2025;31(2):e155-e157. Published online August 30, 2024

DOI: https://doi.org/10.3350/cmh.2024.0723

View: 1303 Download: 50

Anna Brujats, Càndid Villanueva

Clin Mol Hepatol. 2024;30(4):1055-1059. Published online March 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0144

View: 7283 Download: 92 Web of Science: 1 Crossref: 1

Haiyu Wang, Jinjun Chen

Received March 9, 2025 Accepted March 15, 2025

DOI: https://doi.org/10.3350/cmh.2025.0274 [Accepted]

View: 467 Download: 23

Do Seon Song

Received March 13, 2025 Accepted March 20, 2025

DOI: https://doi.org/10.3350/cmh.2025.0296 [Accepted]

View: 361 Download: 34

Haiyu Wang, Jinjun Chen

Received March 23, 2025 Accepted March 28, 2025

DOI: https://doi.org/10.3350/cmh.2025.0326 [Accepted]

View: 383 Download: 13

1 |

Viewed By 12655	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7659	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 7167	MAFLD: How is it different from NAFLD?
Viewed By 5716	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5647	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 369	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 354	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search